Revive Rx Pharmacy is recalling 751 vials of Tirzepatide 10 mg/0.5 mL sterile solution because of a labeling mix-up. The product, which is a compounded weight-loss and diabetes medication, actually contains testosterone cypionate. The recalled medication was sold in 2 mL multi-dose vials and distributed nationwide.
Patients expecting tirzepatide will instead receive testosterone, which can cause significant hormonal imbalances and adverse health effects. Using the incorrect medication may lead to unintended physical changes and complications that require medical attention.
You have 2 options:
Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.